NCT05162898 2022-01-27
Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
Henan Cancer Hospital
Phase NA Unknown
Clinical Trials
14 trialsNCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT04707547 2021-01-13
RFA
Taipei Medical University WanFang Hospital
Phase 4 Completed
NCT00132041 2020-09-10
ACRIN-6673
American College of Radiology Imaging Network
Phase NA Completed
NCT02169765 2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT01486134 2020-05-13
ARMTICH
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT01853618 2019-12-10
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03223142 2017-07-21
SMTATS
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT00510627 2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4 Withdrawn
NCT00019604 2017-02-03
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00093444 2012-03-15
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00922181 2009-11-16
LiverMWA1
University Hospital, Gasthuisberg
Phase NA Completed
NCT00554905 2009-02-10
RFA and TACE
Sun Yat-sen University
Phase 4 Unknown